Cleared Traditional

K201081 - AltaTrack equipment

K201081 is the FDA 510(k) clearance for AltaTrack equipment by Philips Medical System Nederland B.V.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Traditional 510(k) pathway after a 239-day FDA review.

K201081 · Philips Medical System Nederland B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
239d
Days
Class 2
Risk

K201081 is an FDA 510(k) clearance for the AltaTrack equipment, AltaTrack Guidewire, AltaTrack Catheter. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Philips Medical System Nederland B.V. (Best, NL). The FDA issued a Cleared decision on December 17, 2020 after a review of 239 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical System Nederland B.V. devices

Submission Details

510(k) Number K201081 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2020
Decision Date December 17, 2020
Days to Decision 239 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 125d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K201081.
Zio ECG Utilization Software (ZEUS) System
K202527 · iRhythm Technologies, Inc. · May 2021
Spacelabs Lifescreen PRO Analyzer
K201921 · Spacelabs Healthcare, Ltd. · Mar 2021
WorkMate Claris System
K210392 · Abbott · Mar 2021
Graffiti
K202189 · Ge Medical Systems Information Technologies, Inc. · Dec 2020
AcQMap High Resolution Imaging and Mapping System
K201015 · Acutus Medical, Inc. · Dec 2020
CARTO® 3 EP Navigation System with Signal Processing Unit
K200484 · Biosense Webster, Inc. · Nov 2020